NCT05223192

Brief Summary

Infants born prematurely at will be asked to participate in this randomized controlled trial at a corrected gestational age of 24-37 weeks. Infants will be randomly selected to each of the two groups: intervention and control. Infants in the treatment group will receive six intervention days over a two-week period, 3 sessions per week. Each intervention day consists of each of the two interventions in a random sequence: no intervention/silence and live ocean disc instrument intervention. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation. Each infant will thus receive control and ocean disc intervention on the same day in the NICU. Interventions will be given in a randomized order (i.e., first ocean disc or first silence, randomized to AM or PM), with observation occurring for 10 minutes before each intervention, 15 minutes during each intervention, and 10 minutes after each per session. There will be 3 sessions per week for a two-week randomized treatment schedule. For each infant, data on total apnea time, mean respiratory rate, heart rate, O2 levels and behavior rating during will be collected. The sound decibel level will also be recorded and maintained at 40-65dB to prevent overstimulation and hearing damage. Near-infrared light spectroscopy (NIRS) data on cerebral oxygenation will also be collected. Observations will be recorded on the infant's activity or when change occurs, such as a pacifier falling out. Parents and nurses will be asked to behave as they normally would during routine care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

April 8, 2025

Status Verified

April 1, 2025

Enrollment Period

4 years

First QC Date

January 24, 2022

Last Update Submit

April 4, 2025

Conditions

Keywords

music therapyocean discprematurityvital signscerebral oxygenation

Outcome Measures

Primary Outcomes (5)

  • Heart Rate

    14 days

  • Respiratory Rate

    14 days

  • Oxygen-Saturation Level

    14 days

  • Weight

    14 days

  • Cerebral oxygen saturation

    Cerebral oxygen saturation measured using NIRS

    14 days

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in this group will receive the ocean disc music therapy entrainment intervention

Behavioral: Music Therapy Entrainment with Ocean Disc Intervention

Control group

NO INTERVENTION

Participants in this group will not receive any intervention

Interventions

The studied intervention regards live entrainment with the ocean disc. Entrainment involves the use of an external stimulus, in the case of this study, an ocean disc instrument. Motion of the disc creates sounds in synchrony with the breathing of the infant and then in turn can control and influence the infant's regulation of the breath.

Intervention group

Eligibility Criteria

Age24 Weeks - 37 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Newborns born at 24-37 weeks' gestation at Mount Sinai hospital
  • Newborn is considered appropriate for clinically indicated music therapy

You may not qualify if:

  • Infant not expected to survive 24 hours from the time of study entry (To be assessed by a member of the NICU Faculty other than the PI)
  • Infant of uncertain viability (gestation \<23 weeks, birth weight \<500 grams)
  • Known or suspected genetic disorder (e.g., Trisomy 21)
  • Identified hearing disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospitals

New York, New York, 10003, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Joanne V Loewy, DA, MT-BC, LCAT

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joanne V Loewy, DA, MT-BC, LCAT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor

Study Record Dates

First Submitted

January 24, 2022

First Posted

February 3, 2022

Study Start

April 1, 2022

Primary Completion

March 31, 2026

Study Completion

March 31, 2026

Last Updated

April 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

IPD will be made available upon reasonable request to corresponding author

Locations